CD38 expression does not change in B-cell chronic lymphocytic leukemia
- 15 October 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (8) , 3052
- https://doi.org/10.1182/blood-2002-07-2249
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the diseaseBlood, 2002
- CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemiaBritish Journal of Haematology, 2002
- CD38 expression is an important prognostic marker in chronic lymphocytic leukaemiaLeukemia, 2002
- Clinical significance of CD38 expression in chronic lymphocytic leukemiaBlood, 2001
- Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemiaLeukemia Research, 2001
- CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemiaBlood, 2001
- CD38 Expression Correlates with Adverse Biological Features and Predicts Poor Clinical Outcome in B-Cell Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 2001
- Association of CD38 Antigen Expression with Other Prognostic Parameters in Early Stages of Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 2001
- Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic LeukemiaBlood, 1999
- Impact of cryopreservation on B cell chronic lymphocytic leukaemia phenotypeJournal of Immunological Methods, 1999